Brightwell Technologies has appointed Wisbiomed as its exclusive representative in California, Arizona and Nevada
Wisbiomed will market and sell the DPA 4100 micro-flow imaging (MFI) system for the analysis of particle and cell populations.
The DPA 4100 MFI system integrates the most advanced technologies of microfluidics, microscopy and image analysis to measure the size, shape, and concentration of suspended particulate or cells.
The MFI system is used in a wide range of laboratories, such as water/environmental research laboratories for studying the effects of particles and micro-organsisms upon drinkingwater and waste water treatment processes.
The DPA 4100 MFI is also used by biopharmaceutical and industrial process laboratories that have applications for studying and controlling the size and shape of particles.
These applications include reaction monitoring, agglomeration, crystallization, and contamination and cleanliness control.
MFI is also used by cytology laboratories for studying cellular contamination, morphology and viability of a wide range of cells and cell cultures.
Brightwell Technologies designs and manufactures diagnostic instrumentation for analysing cells and particles suspended in liquids.
